Cited by 39Smoking Behavior and CessationSubstance Abuse Treatment and OutcomesDigital Mental Health Interventions

Pilot Randomized Controlled Trial of Web-Delivered Acceptance and Commitment Therapy Versus Smokefree.gov for Smokers With Bipolar Disorder

Open access
Heffner, Jaimee L, Kelly, Megan M, Waxmonsky, Jeanette, Mattocks, Kristin, Serfozo, Edit, Bricker, Jonathan B, Mull, Kristin E, Watson, Noreen L +1 more·2020·Nicotine & Tobacco Research

Abstract

Introduction: Smokers with bipolar disorder (BD) are less successful at quitting than the general population. In this study, we evaluated in a pilot randomized controlled trial a novel, targeted, web-based intervention for smokers with BD based on acceptance and commitment therapy (ACT) and designed for reach and disseminability. Aims and Methods: Daily smokers (n = 51) with bipolar I or II disorder were recruited from four US sites and randomly assigned to one of two web-based smoking cessation interventions—ACT-based WebQuit Plus (n = 25) or Smokefree.gov (n = 26) over a 10-week treatment period. All participants received nicotine patch for 8 weeks. Key outcomes were trial design feasibility, intervention acceptability, and cessation at end of treatment and 1-month follow-up. Results: We screened 119 to enroll 51 participants (target sample size = 60) over 24 months. The most common reason for ineligibility was the inability to attend study appointments. Retention was 73% at end of treatment and 80% at follow-up, with no differences by arm. The mean number of logins was twice as high for WebQuit Plus (10.3 vs. 5.3). The usefulness of program skills was rated higher for WebQuit Plus (75% vs. 29%). Biochemically confirmed, 7-day abstinence at end of treatment was 12% in WebQuit Plus versus 8% in Smokefree.gov (odds ratio = 1.46, 95% confidence interval = 0.21 to 9.97). At follow-up, abstinence rates were 8% in both arms. Conclusions: Trial design produced favorable retention rates, although alternative recruitment methods will be needed for a larger trial. At end of treatment, acceptability and estimated effect size of WebQuit Plus relative to Smokefree.gov were promising and support continued program refinement and evaluation. Implications: In this first randomized controlled trial of a targeted intervention for smokers with BD, we found that the ACT-based WebQuit Plus intervention, delivered in combination with the nicotine patch, had promising acceptability and cessation outcomes relative to Smokefree.gov. The observed signals for acceptability and cessation suggest that the WebQuit Plus program should be refined based on participant feedback and evaluated in a larger trial. Feasibility findings from this study also provide direction for refining trial procedures to enhance the recruitment of smokers with BD.

Integrity signals

Registry

Crossref · 10.1093/ntr/ntz242

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Heffner, J. L., Kelly, M. M., Waxmonsky, J., Mattocks, K., Serfozo, E., Bricker, J. B., Mull, K. E., Watson, N. L., & Ostacher, M.
Affiliations
  • Fred Hutch Cancer Center (US)
  • University of Massachusetts Chan Medical School (US)
  • University of Colorado Anschutz (US)
  • VA Central Western Massachusetts Healthcare System (US)
  • University of Washington (US)
  • VA Palo Alto Health Care System (US)
Corresponding author
Heffner, Jaimee L
Venue
Nicotine & Tobacco Research
Published
2019-12-26
Volume
22
Issue
9
Pages
1543-1552
ISSN
  • 1462-2203 (ISSN-L)
  • 1469-994X
OpenAlex
W2997807317
Cited by
39
References
48
Citations by year
2026: 3 · 2025: 6 · 2024: 6 · 2023: 8 · 2022: 10 · 2021: 4 · 2020: 1 · 2018: 1
FWCI
2.57
Type
journal article
Language
en
Open access
Locations
  • Nicotine & Tobacco Research (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Drug Abuse
  • National Institutes of Health (#R34DA040119)
  • National Network of Depression Centers
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
Keywords
bipolar disorder, smoking cessation, acceptance and commitment therapy, online intervention, nicotine patch, abstinence, treatment acceptability, trial feasibility, recruitment (clinical trials), retention, intervention dissemination, recruitment strategies, participant feedback, participant retention, intervention refinement
MeSH terms
Smokers, Bipolar Disorder, Female, Humans, Male, Middle Aged, Pilot Projects, Tobacco Use Disorder, United States, Health Behavior, Smoking Cessation, Internet, Acceptance and Commitment Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review